DiscoverX Dasatinib
268,50 € HT
Dasatinib is an inhibitor of BCR-ABL, c-Kit, and SRC. Provided as 10mg of dry powder.
- Quantité
- 10 mg
- Marque
- DiscoverX
Dasatinib (Sprycel, BMS-354825) is an oral BCR-ABL, c-KIT, SRC inhibitor (IC50=<1, 79, and 0.8, respectively) and cancer drug developed by Bristol-Myers Squibb. It is most commonly used for treatment of chronic myelogenous leukemia (CML) and philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Inhibits tyrosine kinases via competing for ATP. Provided as 10mg of dry powder.
Caractéristiques techniques
| Marque | DiscoverX |
|---|---|
| Réf. B-LABO | BL-RE-170180 |
| Réf. fabricant | 17322509 |
| Quantité | 10 mg |
Une question, une configuration particulière ?
Contactez-nous pour un devis.
Contactez-nous pour un devis.
Produits similaires
